Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma. / Hughes, D.; Pink, J.; Lane, S. et al.
Yn: Pharmacoeconomics, 19.03.2012.
Yn: Pharmacoeconomics, 19.03.2012.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Pink, J, Lane, S & Hughes, DA 2012, 'Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma.', Pharmacoeconomics. https://doi.org/10.2165/11591540-000000000-00000
APA
Hughes, D., Pink, J., Lane, S., & Hughes, D. A. (2012). Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma. Pharmacoeconomics. https://doi.org/10.2165/11591540-000000000-00000
CBE
Hughes D, Pink J, Lane S, Hughes DA. 2012. Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma. Pharmacoeconomics. https://doi.org/10.2165/11591540-000000000-00000
MLA
Hughes, D. et al. "Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma.". Pharmacoeconomics. 2012. https://doi.org/10.2165/11591540-000000000-00000
VancouverVancouver
Hughes D, Pink J, Lane S, Hughes DA. Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma. Pharmacoeconomics. 2012 Maw 19. doi: 10.2165/11591540-000000000-00000
Author
RIS
TY - JOUR
T1 - Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma.
AU - Hughes, D.
AU - Pink, J.
AU - Lane, S.
AU - Hughes, D.A.
PY - 2012/3/19
Y1 - 2012/3/19
U2 - 10.2165/11591540-000000000-00000
DO - 10.2165/11591540-000000000-00000
M3 - Article
JO - Pharmacoeconomics
JF - Pharmacoeconomics
SN - 1170-7690
ER -